Key result
Pakistan's first national registry details clinical and genetic profiles of Duchenne Muscular Dystrophy patients.
Why the study?
A national registry was needed to better understand the epidemiology and standard of care for Duchenne muscular dystrophy in Pakistan.
Provides initial insights into the clinical and genetic epidemiology of Duchenne Muscular Dystrophy in Pakistan via a national registry.
Answers are grounded in this paper and cite their sources.
Provides first Pakistani DMD registry data; leaves open care standardization pending prospective studies.
This study presents findings characterizing the clinical and genetic profiles of patients with Duchenne Muscular Dystrophy (DMD) from Pakistan’s first national disease registry for Spinal Muscular Atrophy and Duchenne Muscular Dystrophy. The registry is critical to better understanding the epidemiology and standard of DMD patient care in Pakistan.
No takes yet. Share an insight, caveat, or question.
Aziz et al. (2026) studied this question. Pakistan's first national muscular dystrophy registry characterizes the clinical and genetic profiles of patients with Duchenne Muscular Dystrophy to understand epidemiology and standard of care.
Synapse has enriched 10 related papers. Consider them for comparative context: